MétaCan
Menu
Back to cohort
Record W3023702343 · doi:10.1101/2020.05.06.20093260

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcome of COVID-19 : A Systematic Review and Meta-analysis

2020· review· en· W3023702343 on OpenAlexaboutno aff
Aref A. Bin Abdulhak, Tarek Kashour, Anas Noman, Haytham Tlayjeh, Ala Mohsen, Mouaz H. Al‐Mallah, Imad M. Tleyjeh

Bibliographic record

VenuemedRxiv · 2020
Typereview
Languageen
FieldMedicine
TopicCOVID-19 Clinical Research Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMeta-analysisConfidence intervalMedicineOdds ratioRandom effects modelInternal medicineAngiotensin-converting enzymeAngiotensin Receptor BlockersBlood pressure

Abstract

fetched live from OpenAlex

Abstract Importance There is conflicting evidence about the role of angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) in the pathogenesis and outcome of patients infected with acute severe respiratory syndrome coronavirus 2 (SARS-CoV-2) and growing public concerns about their use during this pandemic. Objective We sought to systematically review the literature and perform a meta-analysis about prior use of ACEI/ARBs and outcome of COVID-19 patients. Data source We searched multiple data sources including PubMed, ClinicalTrial.org, and medrxiv.org from November 2019 through May 3, 2020. Study selection Any study that reported on the role of ACEIs / ARBs and outcome of COIVD-19 is eligible. Two authors independently reviewed eligible studies and extracted data into a prespecified data collection form. Data synthesis An inverse variance meta-analytic approach was used to pool adjusted odds ratios using a random effect model meta-analysis. I 2 test was used to assess in between studies heterogeneity. The Newcastle-Ottawa quality assessment scale was used to assess the quality of included studies. Main outcome and Measures The association between the prior use of ACEIs / ARBs and the mortality among SARS-CoV-2 infected patients was assessed using pooled OR and 95% confidence interval. For studies that did not report adjusted effect estimates for mortality, we used their adjusted effect estimate of critical outcome to estimate another pooled OR for critical or fatal outcome and its 95% confidence interval. Results Nine studies were included in this systematic review. The studies included a total of 58,615 patients infected with SARS-CoV-2. Prior use of ACEIs and/or ARBs was associated with a significant reduction of inpatient mortality among SARS-CoV-2 infected patients, with a pooled adjusted OR from 4 studies of 0.33, 95% CI [0.22, 0.49] with no between studies heterogeneity (12=0%) and with a significant reduction of critical or fatal outcome, with a pooled adjusted OR from 5 studies of 0.32, 95% CI [0.22, 0.46] (12 =32%). Conclusion Our meta-analysis suggests that use of ACEIs/ARBs is associated with a decreased risk of death or critical outcome among SARS-CoV-2 infected patients. This finding is limited by the observational nature of the included studies. However, it provides a reassurance to the public not to stop prescribed ACEIs/ARBs due to fear of severe COVID-19. It also calls upon investigators and ethics committees to reconsider the ongoing randomized trials of discontinuation of these drugs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.108
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow), Meta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.863
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.108
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0200.003
Bibliometrics0.0010.002
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.180
GPT teacher head0.453
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations16
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicCOVID-19 Clinical Research StudiesFrench-language works237,207